Answers are grounded in this paper and cite their sources.
The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.
No takes yet. Share an insight, caveat, or question.
Looker et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: